References

Arroll B, Chin W, Martis W Antidepressants for treatment of depression in primary care: a systematic review and meta-analysis. J Prim Health Care. 2016; 8:(4)325-334 https://doi.org/10.1071/HC16008

Castaldelli-Maia JM, Burim Scomparini L, Guerra de Andrade A. Perceptions of and attitudes toward antidepressants: stigma attached to their use--a review. J Nerv Ment Dis.. 2011; 199:(11)866-71 https://doi.org/10.1097/NMD.0b013e3182388950

Ford J, Thomas F, Byng R Use of the Patient Health Questionnaire (PHQ-9) in Practice: Interactions between patients and physicians. Qual Health Res.. 2020; 30:(13)2146-2159 https://doi.org/10.1177/1049732320924625

Hardy S. Mental health and wellbeing: A guide for nurses and allied healthcare professionals working with adults in primary care.Keswick: M&K Publishing; 2021

Hardy S, Gray R. The Primary Care Guide to Mental Health.Keswick: M&K Publishing; 2012

Moir F, Roskvist R, Arroll B Treatment of depression in the first primary care consultation: A qualitative study. J Family Med Prim Care. 2022; 11:(6)2597-2602 https://doi.org/10.4103/jfmpc.jfmpc_1904_21

Mulder R, Hamilton A, Irwin L Treating depression with adjunctive antipsychotics. Bipolar Disord. 2018; 17-24 https://doi.org/10.1111/bdi.12701

National Institute of Health and Care Excellence. Depression: The Treatment and Management of Depression in Adults. Clinical guideline No. 90. 2022. https://www.nice.org.uk/guidance/ng222 (accessed 20 June 2023)

Rubio-Valera M, Beneitez, Peñarrubia-María M Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study). BMC Psychiatry. 2015; 15 https://doi.org/10.1186/s12888-015-0448-3

Solmi M, Miola A, Croatto G How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations. Braz J Psychiatry. 2021; 43:(2)189-202 https://doi.org/10.1590/1516-4446-2020-0935

Trends in the prescribing of antidepressants in primary care. 2014. https://www.nuffieldtrust.org.uk/sites/default/files/2018-10/qualitywatch-antidepressant-prescribing.pdf (accessed 13 June 2023)

Sudak D, Ayub S. Psychotherapeutic Strategies to Enhance Medication Adherence. Psychiatric Times. 2017; 34:(9)22-23

Vos T, Barber R, Bell B Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013. Lancet. 2015; 386:(9995)743-800 https://doi.org/10.1016/S0140-6736(15)60692-4

Woodall A, Walker L. A guide to prescribing antidepressants in primary care. Prescribing in Practice. 2022; 33:(8-9)11-18

Prescribing for depression in primary care

02 July 2023
Volume 5 · Issue 7

Abstract

The term ‘depression’ covers a variety of mental health problems characterised by a loss of interest and enjoyment, low mood and other emotional, cognitive, physical, and behavioural symptoms. Most people experiencing depression are treated in primary care. These treatments include various talking therapies and support to aid physical, psychological and social wellbeing. For people with moderate-to-severe depression, treatment with medication is recommended. This may be prescribed in addition to therapy and support. It is important that the person diagnosed with depression is monitored to assess how they respond to the antidepressants. A different type may need to be offered if response is poor or they have intolerable side effects. Antidepressants need to be prescribed for a given period, the length of which is dependent on whether this is the first or a further episode.

Depression is a condition that can negatively affect how a person feels, thinks and behaves (Hardy, 2021). Although the symptoms of depression vary in every person, commonly people feel sad and find it difficult to engage in the activities they usually enjoy. A variety of emotional and physical problems are experienced, which reduce a person's capacity to perform both at work and at home. Depression has been cited as the second leading cause of disability globally (Vos et al, 2013). Recovery is affected by personality, resilience, family history, premorbid difficulties, relationships and social problems.

The level of severity in depression is determined as sub-threshold depression, mild depression, moderate depression, major depressive disorder (or severe depression). Some people experience persistent depressive disorder where symptoms are mild but affect functioning due to the duration experienced. The severity of depression can be measured using the Patient Health Questionnaire (PHQ-9). This is a nine-question tool which has been validated for use in primary care (Ford et al, 2020).

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month